OneMedNet (NASDAQ:ONMD – Get Free Report) and Medpace (NASDAQ:MEDP – Get Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.
Analyst Recommendations
This is a summary of current ratings and price targets for OneMedNet and Medpace, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
OneMedNet | 0 | 0 | 0 | 0 | N/A |
Medpace | 0 | 1 | 3 | 0 | 2.75 |
Medpace has a consensus target price of $382.00, indicating a potential upside of 2.05%. Given Medpace’s higher probable upside, analysts plainly believe Medpace is more favorable than OneMedNet.
Volatility and Risk
Valuation & Earnings
This table compares OneMedNet and Medpace’s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
OneMedNet | $1.02 million | 15.18 | -$23.20 million | ($0.19) | -3.42 |
Medpace | $1.89 billion | 6.15 | $282.81 million | $8.88 | 42.15 |
Medpace has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares OneMedNet and Medpace’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
OneMedNet | N/A | N/A | -116.74% |
Medpace | 15.00% | 63.98% | 19.02% |
Insider and Institutional Ownership
1.0% of OneMedNet shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 45.7% of OneMedNet shares are owned by company insiders. Comparatively, 20.3% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Medpace beats OneMedNet on 11 of the 13 factors compared between the two stocks.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.
About Medpace
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.